This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Aortic body and other paraganglia
DOID EFO MESH SNOMED Endpoint Browser
CD2_BENIGN_AORTICBODY_PARAGANGLIA
adenoma: The congenital absence of the thyroid gland.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
D35.6&
Hospital discharge: ICD-9
2276
Cause of death: ICD-10
D35.6&
Cause of death: ICD-9
2276
2 out of 7 registries used, show all original rules.
23
Check minimum number of events None
23
Include endpoints None
23
Remove individuals based on genotype QC
23
CD2_BENIGN_AORTICBODY_PARAGANGLIA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D35
Name in latin
Neoplasma benignum glomeris aortici
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Aortic body and other paraganglia
based on the number of shared cases.
Broader endpoints:
- Benign neoplasm: Aortic body and other paraganglia (controls excluding all cancers)
- Benign neoplasm of other and unspecified endocrine glands
- Benign neoplasm of other and unspecified endocrine glands (controls excluding all cancers)
- Benign neoplasms (controls excluding all cancers)
- Benign neoplasms
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 23 | 15 | 8 |
| Unadjusted prevalence (%) | 0.01 | 0.01 | 0.00 |
| Mean age at first event (years) | 46.50 | 42.69 | 53.64 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_BENIGN_AORTICBODY_PARAGANGLIA – Benign neoplasm: Aortic body and other paraganglia
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Benign neoplasm: Aortic body and other paraganglia
↥Endpoint not on priority list, no data to show.